Stroke, Vol 21, 948-952, Copyright © 1990 by American Heart Association
JC Grotta, CM Picone, R Earls, R Strong, L Yao and JR Dedman
Calcium channel blockers such as nicardipine improve outcome after global
cerebral ischemia and may attenuate ischemic neuronal injury by preventing
calcium influx and binding to calmodulin. We followed the temporal and
regional sequence of neuronal calcium-calmodulin binding in normal rats (n
= 6), untreated ischemic rats (n = 15), and ischemic rats treated with 0.05
mg/kg/hr s.c. nicardipine (n = 13). After 30 minutes of four-vessel
occlusion, 40-microns brain sections were incubated in an anti-calmodulin
antibody specific for calmodulin not bound to calcium and brain protein.
Light-microscopic sections were examined immediately after ischemia and
after 2 and 24 hours of reperfusion. Extensive staining of unbound
calmodulin was seen in all hippocampal regions and in the cortex in normal
rats. In untreated ischemic control rats, staining was lost, indicating
calcium-calmodulin binding immediately after ischemia in all regions.
However, after 24 hours, staining returned to normal in the cortex and
dentate, and minimal staining returned in CA1 and CA3. Nicardipine-treated
animals had significantly less calcium-calmodulin binding in CA1 and in the
dentate after 2 hours of reperfusion. This study demonstrates that in
clinically relevant doses nicardipine has a limited effect on calcium-
calmodulin binding in selectively vulnerable regions after severe ischemia.
ARTICLES
Calcium-calmodulin binding in ischemic rat neurons after calcium channel blocker therapy
Department of Neurology, University of Texas Medical School, Houston 77030.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |